Disruptive Technology Channel How Will Netanyahu’s Departure Affect the Israeli Economy? By Tom LydonJune 16, 2021
Disruptive Technology Channel Biogen Alzheimer’s Approval Could Signal FDA’s Flexibility By Tom LydonJune 15, 2021
Disruptive Technology Channel ‘ARKK’ Is Still the Prime Avenue to Disruptive Investing By Tom LydonJune 11, 2021
Disruptive Technology Channel Why to Invest in ARKQ, Artificial Intelligence By Tom LydonJune 10, 2021
Disruptive Technology Channel Why to Consider ARKX, Two Old-School Aerospace Stocks By Tom LydonJune 9, 2021
Disruptive Technology Channel New Spate of Cyber Attacks Adds to Intrigue with ARK’s ‘IZRL’ By Tom LydonJune 7, 2021
Disruptive Technology Channel Pandemic Opening the Door for Widespread Genetic Testing By Tom LydonJune 2, 2021
Disruptive Technology Channel A Value Rotation Could Actually Benefit Disruptive Stocks By Tom LydonJune 1, 2021
Disruptive Technology Channel It’s Not Too Late to Join the 3D Printing Party By Tom LydonMay 27, 2021
Disruptive Technology Channel A Base Hit: How Base Editing Is Changing Genomics By Tom LydonMay 26, 2021
Disruptive Technology Channel The ARKK ETF: Bold Breadth to Disruptive Depth By Todd ShriberMay 19, 2021
Disruptive Technology Channel How Genomics Is Improving Cancer Screening, Investing By Tom LydonMay 18, 2021